Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.

Balance Sheet for PharmaCyte Biotech Inc (PMCB)

$ 0.075455   -0.001545 (-2.01%) Volume: 816.79k 3:59 PM EDT May 22, 2017
Statement: View:
Assets [+] in Thousands of Dollars
04/2016 04/2015 04/2014 04/2013 04/2012
Cash and Equivalents 1,921 2,700 3,616 199 16
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable - - - - 3
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - - 3
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - 7
Inventories, Other - - - - 7
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - 7
Prepaid Expenses 110 1,468 570 1,649 1,034
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 2,031 4,168 4,187 1,848 1,059
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment - - - 24 24
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total - - - 24 24
Gross Fixed Assets - - - 24 24
Accumulated Depreciation - - - (24) (24)
Net Fixed Assets - - - - -
Intangibles 3,549 3,549 3,549 - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 8 8 8 - -
Total Non-Current Assets 5,129 5,129 5,129 1,029 1,029
Total Assets 7,160 9,297 9,316 2,877 2,088
Liabilities [+] in Thousands of Dollars
04/2016 04/2015 04/2014 04/2013 04/2012
Accounts Payable 336 497 332 1,025 1,276
Short Term Debt - - - 420 2,092
Notes Payable - - - - -
Accrued Expenses 151 22 42 12 419
Accrued Liabilities 151 22 42 12 419
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities 150 1,001 - 2,341 -
Total Current Liabilities 638 1,520 374 3,798 3,787
Long Term Debt - - - - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - (500) - -
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities - - (500) 580 580
Total Liabilities 638 1,520 (126) 4,378 4,367
Preferred Shareholder's Equity - - 500 580 580
Common Shareholder's Equity 6,523 7,777 8,942 (2,081) (2,860)
Common Par 78 73 69 48 42
Additional Paid in Capital 91,135 86,330 75,999 39,896 37,527
Cumulative Translation Adjustments - - - - -
Retained Earnings (84,692) (78,628) (68,700) (41,446) (39,848)
Treasury Stock - - - - -
Other Equity Adjustments 1 1 - - -
Total Capitalization 6,523 7,777 9,442 (1,501) (2,280)
Total Equity 6,523 7,777 9,442 (1,501) (2,280)
Total Liabilities & Shareholder's Equity 7,160 9,297 9,316 2,877 2,088
Cash Flow (6,064) (9,928) (27,254) (1,597) (1,913)
Working Capital 1,393 2,648 3,813 (1,950) (2,729)
Free Cash Flow (4,346) (5,060) (5,063) (1,037) (259)
Invested Capital 6,523 7,777 8,942 (1,501) (2,280)
Shares Outstanding - Common Class Only 781,233 732,760 690,616 482,106 416,293
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 781,233 732,760 690,616 482,106 416,293
Total Common Shares Outstanding 781,233 732,760 690,616 482,106 416,293
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 752,403 704,328 583,220 440,955 374,764
Diluted Weighted Shares Outstanding 752,403 704,328 690,616 482,106 374,764